111 related articles for article (PubMed ID: 3999857)
1. [Plafibride--is it an effective drug as a hypolipemic agent?].
Joven J
Med Clin (Barc); 1985 Apr; 84(15):632. PubMed ID: 3999857
[No Abstract] [Full Text] [Related]
2. [Therapy of vascular insufficiency of the legs with plafibride].
Lázaro Campillo T; Gesto Castromil R; de la Sierra L; Pujadas J; Villafana W; Moreno R
Med Clin (Barc); 1984 Dec; 83(18):752-5. PubMed ID: 6521538
[No Abstract] [Full Text] [Related]
3. [Plafibride and vascular insufficiency of the lower limbs].
Soringer Escofet FJ; Esteva de Antonio I
Med Clin (Barc); 1985 Apr; 84(15):632. PubMed ID: 3999856
[No Abstract] [Full Text] [Related]
4. Hypolipemic profile of plafibride in a model of experimental atherosclerosis.
Badimón JJ; Padró T; Cánovas M; Vidal M; Villaverde CA
Methods Find Exp Clin Pharmacol; 1983 Nov; 5(9):613-7. PubMed ID: 6668971
[TBL] [Abstract][Full Text] [Related]
5. Clinical research into the hypolipemic and platelet antiaggregant activity of plafibride, Carried out in double-blind conditions and in comparison with clofibrate.
Palmieri B; Gasparini Casari M; DiBlasio P; Zirilli E
Arzneimittelforschung; 1981; 31(10a):1863-6. PubMed ID: 7032534
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of ischemic ulcers of the lower extremities using plafibride].
Palou Monzo J; López-Delmás FJ
Angiologia; 1984; 36(6):273-8. PubMed ID: 6517385
[No Abstract] [Full Text] [Related]
7. [Plafibride treatment of hyperlipidemias type II and IV].
Soler J; Vinzia C; Gómez JM; Morató J
Med Clin (Barc); 1984 May; 82(19):840-2. PubMed ID: 6738212
[No Abstract] [Full Text] [Related]
8. Clinical trials of plafibride in geriatric patients.
Demichelis Genesio MA; Bracons R; Vicens B; Zapatero J; Bruseghini L
Arzneimittelforschung; 1981; 31(10a):1852-5. PubMed ID: 7198465
[TBL] [Abstract][Full Text] [Related]
9. [Double-blind study of the therapeutic activity of a new hypolipemic drug: etofibrate].
Altomonte L; Mingrone G; Negrini A; De Cunto F; Greco AV
Clin Ter; 1981 Jan; 96(1):31-8. PubMed ID: 7016409
[No Abstract] [Full Text] [Related]
10. Hypolipemic activity of plafibride.
Bruseghini L; Vilageliu J; Bagaria A
Arzneimittelforschung; 1981; 31(10a):1796-800. PubMed ID: 7198456
[TBL] [Abstract][Full Text] [Related]
11. [Hypolipemic effect of amino acid derivatives of clofibric acid].
Wójcicki J; Samochowiec L; Gawrońska-Szklarz B; Kwapiszewski W; Borkowski L
Acta Pol Pharm; 1985; 42(3):305-8. PubMed ID: 4096253
[No Abstract] [Full Text] [Related]
12. Plafibride tolerance trial in healthy volunteers.
Dalmau J; Vicens B; Zapatero J; Bruseghini L
Arzneimittelforschung; 1981; 31(10a):1845-9. PubMed ID: 7198463
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic approach of plafibride in rat.
Zapatero D; Vilageliu J; Torres A; Ribalta JM; Bruseghini L
Arzneimittelforschung; 1981; 31(10a):1800-4. PubMed ID: 7198457
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacology and mechanism of action of etofibrate].
Schatton W
Med Welt; 1982 Sep; 33(38):1310-4. PubMed ID: 6752630
[No Abstract] [Full Text] [Related]
15. [Study of the antilipemic effect of etofibrate (Lipo-Merz)].
Słowińska R; Bochenek W; Unlot J
Pol Tyg Lek; 1983 Apr; 38(17):529-32. PubMed ID: 6356087
[No Abstract] [Full Text] [Related]
16. [Lipid therapy with etofibrate. Reduction of multiple risk factors with an active substance. Report of an international seminar. 8-11 November 1989, Houston, Texas].
Fortschr Med Suppl; 1990; 85():1-15. PubMed ID: 2338325
[No Abstract] [Full Text] [Related]
17. Plafibride tolerance trial at increasing doses in healthy volunteers.
Dalmau J; Vicens B; Zapatero J; Bruseghini L
Arzneimittelforschung; 1981; 31(10a):1840-4. PubMed ID: 7198462
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic effects of bezafibrate in hyperlipidemia].
Kunesová M; Honková M; Zeman M; Mares P; Skorepa J
Cas Lek Cesk; 1983 May; 122(20):628-31. PubMed ID: 6342789
[No Abstract] [Full Text] [Related]
19. [Etofibrate in severe diet-refractory cases of hyperlipoproteinemia].
Schatton W; Holm E
Fortschr Med; 1986 Apr; 104(13):280-2. PubMed ID: 3699655
[No Abstract] [Full Text] [Related]
20. Influence of plafibride, an antiplatelet and hypolipemic agent, on prostacyclin and thromboxane synthesis, 3',5'-cyclic AMP phosphodiesterase activity and serum clearance of a lipid emulsion.
Vilageliu J; Freixes J; Giráldez A; Bermejo P; Basi N; Bruseghini L
Arzneimittelforschung; 1981; 31(10a):1805-7. PubMed ID: 6274363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]